IRIS
MUSANTE, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.758
AS - Asia 44
NA - Nord America 2
Totale 4.804
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.758
CN - Cina 43
US - Stati Uniti d'America 2
SG - Singapore 1
Totale 4.804
Salva come PNG Salva come JPEG
Città #
Genova 2.026
Genoa 1.828
Rapallo 454
Vado Ligure 440
Beijing 17
Bordighera 5
Milan 5
Ashburn 2
Totale 4.777
Salva come PNG Salva come JPEG
Nome #
Assessment of copy number variations in 120 patients with Poland syndrome 206
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 203
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 197
Compensatory Molecular and Functional Mechanisms in Nervous System of the Grm1crv4 Mouse Lacking the mGlu1 Receptor: A Model for Motor Coordination Deficits. 171
Goblet Cell Hyperplasia Requires High Bicarbonate Transport To Support Mucin Release 169
Phenotypic characterization of Grm1crv4 mice reveals a functional role for the type 1 metabotropic glutamate receptor in bone mineralization 154
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 143
De novo deletion of chromosome 11q12.3 in monozygotic twins affected by Poland Syndrome 142
Compensatory molecular and functional mechanisms in neurons of the Grm1crv4 mouse, a murine model for ataxia lacking the mGlu1 receptor. 122
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 121
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 118
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 116
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 114
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 112
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 111
Compensatory molecular and functional mechanisms in neurons of the Grm1crv4 mouse, a murine model for ataxia lacking the mGlu1 receptor 109
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 109
Targeting group i metabotropic glutamate receptors in experimental als. 101
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 99
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 97
Genetic inactivation of metabotropic glutamate 5 (mGlu5) receptor ameliorates motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 97
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells 96
Reducing the expression of mGlu1 and mGlu5 receptors ameliorates survival and disease progression in SOD1G93A mice 93
A Phenotypic-Driven Approach for the Diagnosis of WOREE Syndrome 92
Inactivation of the Grm5 gene improves motor coordination defects in the Grm1crv4 mouse model of SCAR13 ataxia 90
Knocking-down mGluR1 and mGluR5 in SOD1G93A mice ameliorates survival and disease progression 88
Partial deletion of mGluR1 receptors prolongs life span and ameliorates motor skills and biochemical and cellular parameters in a mouse model of experimental ALS 86
Reducing excitotoxicity knocking down mGluR1: prolonged survival and improved symptomatology of SOD1/G93A mouse model of ALS 86
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 82
Genotype-phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders 82
Partial rescue of f508del-cftr stability and trafficking defects by double corrector treatment 82
Comprehensive analysis of combinatorial pharmacological treatments to correct nonsense mutations in the cftr gene 79
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 78
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism 77
Whole exome sequencing (WES) and functional analyses suggest synergistic effects of deleterious variants in two candidate genes for Poland Syndrome 77
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 75
Phenotypic Characterization of Grm1crv4 Mice Reveals a Functional Role for the Type 1 Metabotropic Glutamate Receptor in the Skeleton 75
Brain Organoids as Model Systems for Genetic Neurodevelopmental Disorders 72
Intermolecular interactions in the TMEM16A dimer controlling channel activity 71
Targeting alternative splicing as a potential therapy for episodic ataxia type 2 67
Two CFTR mutations within codon 970 differently impact on the chloride channel functionality 63
Allelic heterogeneity and abnormal vesicle recycling in PLAA-related neurodevelopmental disorders 62
Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation 59
Vesicular glutamate release from feeder-free hiPSC-derived neurons 58
Increased expression of ATP12A proton pump in cystic fibrosis airways 52
Reactive Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how mGlu5 receptor modulation affects pathological features 51
De novo variants in DENND5B cause a neurodevelopmental disorder 51
Peripheral localization of the epithelial sodium channel in the apical membrane of bronchial epithelial cells 47
Generation of two iPSC lines from Mowat-Wilson syndrome patients carrying heterozygous ZEB2 mutations 45
Changes of the microglia phenotype in the SOD1G93A mouse model of amyotrophic lateral sclerosis after mGluR5 genetic down-regulation 39
Reactive phenotype and oxidative stress in i-Astrocytes from patients affected by Amyotrophic Lateral Sclerosis: how the mGluR5 negative allosteric modulator CTEP affects these pathological features 29
KCa3.1 differentially regulates trachea and bronchi epithelial gene expression in a chronic-asthma mouse model 13
CACNA1A loss-of-function affects neurogenesis in human iPSC-derived neural models 11
Totale 4.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.163
article - articoli 12.089
book - libri 0
conference - conferenze 6.074
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 0 0 0 31 6 16 35 48 32 37 26 12
2021/2022422 6 35 28 41 17 22 16 100 25 40 27 65
2022/2023530 46 50 7 35 86 83 1 37 95 2 73 15
2023/2024383 13 46 9 52 27 79 29 14 18 15 23 58
2024/20251.308 46 82 24 79 137 116 99 257 80 62 156 170
2025/2026573 267 67 120 119 0 0 0 0 0 0 0 0
Totale 4.939